Related Experiment Video
Updated: Jun 18, 2026
06:57
Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
Published on: August 11, 2018
Innovative Protein Nanostructures and Hybrid Systems for Enhanced Encapsulation and Controlled Delivery of Bioactive
Chandani Chandarana1, Anandha Krishnan1, Anjana Bera2
1SSR College of Pharmacy, Sayli, Silvassa, 396230, India.
Current Protein & Peptide Science
|June 17, 2026
Summary
Protein-based encapsulation systems offer enhanced stability and targeted delivery of bioactive compounds. Novel designs and modifications improve protection against degradation and control release for food and biomedical applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Proteins are versatile carriers for bioactive compounds due to biocompatibility and biodegradability.
- Environmental factors can compromise protein-based delivery system performance.
- Novel structural designs and modifications are needed to enhance protein carrier efficacy.
Purpose of the Study:
- To review novel structural designs and modification strategies for protein-based delivery systems.
- To improve encapsulation efficiency, stability, and targeted delivery of bioactive compounds.
- To analyze encapsulation efficiency, protection against degradation, controlled release, and bioavailability enhancement.
Main Methods:
- Review of protein architectures: self-assembled nanostructures, nanoparticles, micelles, hydrogels, and hybrid protein-polymer systems.
- Discussion of techniques: coacervation, crosslinking, stimuli-responsive mechanisms, spray drying, enzymatic cross-linking, protein-polymer conjugation.
- Analysis of codelivery platforms and surface functionalization.
Main Results:
- Novel protein structures (nanocages, hybrid composites) show superior encapsulation and protection against degradation.
- Cross-linking and stimuli-responsive carriers facilitate targeted and controlled release.
- Advanced techniques enhance mechanical and chemical stability, improving absorption and therapeutic efficacy.
Conclusions:
- Innovative protein-based delivery systems with tailored modifications overcome traditional limitations in encapsulation, protection, and controlled release.
- Protein engineering and nanotechnology advancements are key for optimizing systems for clinical and industrial use.
- Scalability and enzymatic degradation remain challenges for widespread application.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.